Children’s Cancer Cause survey underscores the need for lifelong survivorship care, mental health support, and strong government investment in research. Read more: https://fox5sandiego.com/business/press-releases/ein-presswire/849874197/survey-childhood-cancer-survivors-seek-more-support-from-healthcare-providers-peers-and-policymakers/

Dr. Kim E. Nichols leans on findings from the Pediatric Cancer Genome Project to discover the role genes and ancestry play in the development of cancer. Read more: https://www.stjude.org/inspire/news/dr-kim-nichols-cancer-predisposition-clinic.html

Carboplatin plus etoposide, with or without focal treatments, may be safe and effective for patients with high-risk intraocular retinoblastoma, according to phase 2 results published in Cancer Medicine . Read more: https://www.cancertherapyadvisor.com/news/combo-safe-effective-high-risk-intraocular-retinoblastoma/

"Even though naxitamab appeared to have erased the cancer, Dr. Modak wanted to do everything possible to prevent the high-risk neuroblastoma from returning. He proposed that James receive a pioneering treatment: a cancer vaccine that would train his immune system to continuously be on guard to spot and fight malignant cells." Read more: https://www.mskcc.org/news/cancer-vaccine-could-prevent-neuroblastoma-from-returning-after-antibody-treatment

Inspired by sister’s leukemia treatment, oncology researcher helps transform care, resulting in a near 90% survival rate for stem cell transplants. Read more: https://www.ucsf.edu/news/2025/08/430571/new-approach-smarter-safer-cancer-treatment

A study looking at the biophysical properties of an abnormal protein driving cancer cells is giving scientists new therapeutic clues for how to treat ependymoma, the third most common childhood brain tumor. Read more: https://www.news-medical.net/news/20250827/Abnormal-fusion-protein-drives-childhood-brain-tumor-through-condensate-formation.aspx

The study found that restricting the cancer’s access to an essential nutrient called arginine yielded promising results, both when used on its own and when used in combination with standard therapies.  Read more: https://www.ccia.org.au/blog/potential-new-treatment-strategy-for-high-risk-neuroblastoma

A new study delving into the genetic drivers of a rare and aggressive childhood cancer called Malignant Peripheral Nerve Sheath Tumor...

For children in families that are facing cancer, back to school season can be a particularly tumultuous time of year, as an expert...

A new study, led by researchers at Children's Hospital of Philadelphia (CHOP), identified tiny pieces of messenger RNA that are missing...